Literature DB >> 27094941

Isolated abdominal aortitis following administration of granulocyte colony stimulating factor (G-CSF).

Edward B Miller1,2,3, Roy Grosu4, Zvi Landau5.   

Abstract

G-CSF is a myeloid growth factor produced by monocytes, macrophages, fibroblasts, and endothelial cells. Clinical uses of G-CSF includes mobilization of peripheral blood progenitor cells from healthy donors before hematopoietic stem cell transplantation, acceleration of neutrophil recovery following chemotherapy, and in the management of neutropenia due to other causes including AIDS and genetic disorders of granulocyte production. G-CSF is well tolerated and reports to be safe in healthy donors, although follow-up studies are limited in duration (D'Souza et al. in Transfus Med Rev 22(4):280-290, 2008).Isolated abdominal aortitis (IAA) is a rare disorder most commonly caused by the large-vessel vasculitides giant cell arteritis (GCA) and Takayasu arteritis, although it may also be associated with several other rheumatologic diseases and infections (Gornik and Creager in Circulation 117:3039-3051, 2008). To our knowledge, there only two cases have been published of IAA occurring in patients who had received G-CSF therapy (Dariea et al. in Rev Med Interne 25(3):225-229, 2004; Adiga et al. in Clin Drug Investig 29:821-825, 2009).We describe a case of a 55-year-old male, with peripheral vascular disease who after receiving Neupogen (G-CSF) developed a latent case of IAA. After further investigation and exclusion of other possible causative factors, we conclude that the most probable etiology is induction by G-CSF.

Entities:  

Keywords:  Aortitis; G-CSF; Granulocyte colony-stimulating factor

Mesh:

Substances:

Year:  2016        PMID: 27094941     DOI: 10.1007/s10067-016-3253-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  9 in total

1.  The Sweet syndrome during therapy with granulocyte colony-stimulating factor.

Authors:  J W Park; B Mehrotra; B O Barnett; A D Baron; A P Venook
Journal:  Ann Intern Med       Date:  1992-06-15       Impact factor: 25.391

2.  Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte colony-stimulating factor for Felty's syndrome.

Authors:  B Vidarsson; A J Geirsson; P T Onundarson
Journal:  Am J Med       Date:  1995-06       Impact factor: 4.965

3.  Abdominal aortitis after use of granulocyte colony-stimulating factor.

Authors:  Giridhar U Adiga; Dahlia Elkadi; Sandeep K Malik; Jill D Fitzpatrick; Stefan Madajewicz
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

4.  G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases.

Authors:  Anke Franzke; Wenji Piao; Jörg Lauber; Patricia Gatzlaff; Christian Könecke; Wiebke Hansen; Angela Schmitt-Thomsen; Bernd Hertenstein; Jan Buer; Arnold Ganser
Journal:  Blood       Date:  2003-04-03       Impact factor: 22.113

5.  Leukocytoclastic vasculitis as a complication of granulocyte colony-stimulating factor (G-CSF) -- a case study.

Authors:  M V Andavolu; L J Logan
Journal:  Ann Hematol       Date:  1999-02       Impact factor: 3.673

6.  Granulocyte colony-stimulating factor induces disease flare in patients with antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Christof Iking-Konert; Benedikt Ostendorf; Mark Foede; Rebecca Fischer-Betz; Gregor Jung; Maria G Haensch; Matthias Schneider
Journal:  J Rheumatol       Date:  2004-08       Impact factor: 4.666

Review 7.  Granulocyte colony-stimulating factor administration: adverse events.

Authors:  Anita D'Souza; Ishmael Jaiyesimi; Lance Trainor; Padmaja Venuturumili
Journal:  Transfus Med Rev       Date:  2008-10

8.  [Aortitis after G-CSF injections].

Authors:  C Darie; S Boutalba; P Fichter; J-F Huret; P Jaillot; F Deplus; S Gerenton; T Zenone; J-L Moreau; A Grand
Journal:  Rev Med Interne       Date:  2004-03       Impact factor: 0.728

Review 9.  Cutaneous vasculitis associated with granulocyte colony-stimulating factor.

Authors:  K K Jain
Journal:  J Am Acad Dermatol       Date:  1994-08       Impact factor: 11.527

  9 in total
  7 in total

1.  A retrospective analysis on arteritis after administration of granulocyte colony-stimulating factor.

Authors:  Ken Sasaki; Kensuke Matsuda; Masashi Miyauchi; Akira Honda; Arika Shimura; Yosuke Masamoto; Mineo Kurokawa
Journal:  Ann Hematol       Date:  2021-03-30       Impact factor: 3.673

2.  Granulocyte colony-stimulating factor- and chemotherapy-induced large-vessel vasculitis: six patient cases and a systematic literature review.

Authors:  Kirsi Taimen; Samu Heino; Ia Kohonen; Heikki Relas; Riikka Huovinen; Arno Hänninen; Laura Pirilä
Journal:  Rheumatol Adv Pract       Date:  2020-02-06

Review 3.  Granulocyte-colony stimulating factor-associated aortitis in a woman with advanced breast cancer: a case report and review of the literature.

Authors:  Hideko Hoshina; Hiroyuki Takei
Journal:  BMC Cancer       Date:  2019-12-16       Impact factor: 4.430

Review 4.  Role of Neutrophils in Systemic Vasculitides.

Authors:  Despina Michailidou; Tomas Mustelin; Christian Lood
Journal:  Front Immunol       Date:  2020-12-17       Impact factor: 7.561

5.  Granulocyte colony stimulating factor-associated aortitis evaluated via multiple imaging modalities including vascular echography: a case report.

Authors:  Mikiko Harada; Hirohiko Motoki; Takahiro Sakai; Koichiro Kuwahara
Journal:  Eur Heart J Case Rep       Date:  2020-12-23

6.  Granulocyte colony-stimulating factor associated arteritis in a patient with castration-resistant prostate cancer.

Authors:  Satoshi Nitta; Takazo Tanaka; Ryota Yanagihashi; Haruna Nonaka; Shuhei Suzuki; Tomokazu Kimura; Shuya Kandori; Akio Hoshi; Hiromitsu Negoro; Hiroyuki Nishiyama
Journal:  IJU Case Rep       Date:  2021-09-21

7.  Pegfilgrastim-induced vasculitis of the subclavian and basilar artery complicated by subarachnoid hemorrhage in a breast cancer patient: a case report and review of the literature.

Authors:  Yukiko Seto; Nobuyoshi Kittaka; Azusa Taniguchi; Haruka Kanaoka; Satomi Nakajima; Yuri Oyama; Hiroki Kusama; Noriyuki Watanabe; Saki Matsui; Minako Nishio; Fumie Fujisawa; Koji Takano; Hideyuki Arita; Takahiro Nakayama
Journal:  Surg Case Rep       Date:  2022-08-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.